Skip to main content
. 2023 Apr 17;14:1119168. doi: 10.3389/fimmu.2023.1119168

Figure 6.

Figure 6

Sensitivity analysis of the meta-analysis: (A) OS in PD-L1 expression; (B) RFS in PD-L1 expression; (C) TTR in PD-L1 expression; (D) OS in PD1 expression; (E) RFS in PD1 expression. PD-L1, programmed cell death ligand 1; OS, overall survival; RFS, recurrence-free survival.